tiprankstipranks
QSAM Biosciences (QSAM)
OTHER OTC:QSAM
US Market

QSAM Biosciences (QSAM) Income Statement

5 Followers

QSAM Biosciences Income Statement

Last quarter (Q3 2023), QSAM Biosciences's total revenue was $-5.18K, a decrease of -Infinity% from the same quarter last year. In Q3, QSAM Biosciences's net income was $-1.25M. See QSAM Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ -426.10K$ -20.11K$ -935.80K$ 0.00$ 0.00$ 33.33K
Cost of Revenue
-----$ 0.00
Gross Profit
-----$ 33.33K
Operating Expense
---$ 1.32M$ 1.13M$ 1.61M
Operating Income
---$ -1.32M$ -1.13M$ -1.58M
Net Non Operating Interest Income Expense
---$ -490.40K$ -540.88K$ -346.02K
Other Income Expense
---$ -4.01M$ 1.04M$ 1.53M
Pretax Income
$ -5.09M$ -5.48M$ -12.01M$ -5.82M$ -634.28K$ -397.26K
Tax Provision
$ 7.20K-$ 89.26K$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -6.84M$ -6.07M$ -13.55M$ -4.90M$ -717.98K$ -438.02K
Basic EPS
$ -4.40$ -3.45-$ -35.20$ -0.25$ -0.25
Diluted EPS
$ -1.69$ -3.45-$ -35.20$ -0.25$ -0.25
Basic Average Shares
$ 10.20M$ 1.76M$ 791.60K$ 138.07K$ 2.08M$ 1.99M
Diluted Average Shares
$ 8.75M$ 1.76M$ 791.60K$ 138.07K$ 2.08M$ 1.99M
Dividend Per Share
$ 0.75-----
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
---$ 1.32M$ 1.13M$ 1.61M
Net Income From Continuing And Discontinued Operation
$ -5.47M$ -5.48M$ -12.86M$ -4.86M$ -681.98K$ -397.26K
Normalized Income
$ -1.90M--$ -5.55M$ -612.69K$ -397.26K
Interest Expense
$ 480.38K$ 74.39K$ 44.17K$ 490.40K$ 540.88K$ 346.02K
EBIT
$ -2.68M-$ -12.01M$ -5.33M$ -93.40K$ -51.24K
EBITDA
$ -2.64M-$ -12.01M$ -5.33M$ -93.05K$ -51.04K
Currency in USD

QSAM Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis